Related Experiment Video
Updated: Jun 12, 2026

Interview: Bioreactors and Surfaced-Modified 3D-Scaffolds for Stem Cell Research
Published on: May 21, 2008
Pharma's developing interest in stem cells
Ruth McKernan1, John McNeish, Devyn Smith
1Pfizer Regenerative Medicine, Cambridge, UK. ruth.mckernan@pfizer.com
Abstract:
Human stem cell biology is driving the promise of novel regenerative therapies into clinical trials. Although the pharmaceutical industry has embraced stem cells as tools in drug discovery, few companies have taken the risk to deliver stem cell-based medicines. Here, we evaluate the various cell-based opportunities and corporate strategies.
Related Concept Videos
Stem Cell Culture
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Source And Potency Of Stem Cells
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...
Induced Pluripotent Stem Cells

